Cedres, S.; Valdivia, A.; Iranzo, P.; Callejo, A.; Pardo, N.; Navarro, A.; Martinez-Marti, A.; Assaf-Pastrana, J.D.; Felip, E.; Garrido, P.
Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy. Cancers 2023, 15, 5787.
https://doi.org/10.3390/cancers15245787
AMA Style
Cedres S, Valdivia A, Iranzo P, Callejo A, Pardo N, Navarro A, Martinez-Marti A, Assaf-Pastrana JD, Felip E, Garrido P.
Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy. Cancers. 2023; 15(24):5787.
https://doi.org/10.3390/cancers15245787
Chicago/Turabian Style
Cedres, Susana, Augusto Valdivia, Patricia Iranzo, Ana Callejo, Nuria Pardo, Alejandro Navarro, Alex Martinez-Marti, Juan David Assaf-Pastrana, Enriqueta Felip, and Pilar Garrido.
2023. "Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy" Cancers 15, no. 24: 5787.
https://doi.org/10.3390/cancers15245787
APA Style
Cedres, S., Valdivia, A., Iranzo, P., Callejo, A., Pardo, N., Navarro, A., Martinez-Marti, A., Assaf-Pastrana, J. D., Felip, E., & Garrido, P.
(2023). Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy. Cancers, 15(24), 5787.
https://doi.org/10.3390/cancers15245787
